by Research antibodies play a crucial role in a wide range of research applications including clinical research, drug discovery, proteomics, cellular analysis, and genomics. Research antibodies facilitate in identifying novel biomarkers, determining protein function, detecting antigens, and measuring protein expression levels through various diagnostic and analytical techniques. The increasing research and development activities in the pharmaceutical and biotechnology industries to develop targeted therapeutics is significantly fueling the demand for research antibodies. Research antibodies are widely utilized in the development of monoclonal antibodies that represent the fastest growing class of therapeutic drugs to treat various chronic diseases including cancer.
The global research antibodies market is estimated to be valued at US$ 3785.5 Bn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The research antibodies market is witnessing noteworthy advancements with the introduction of technologies to develop humanized antibodies. Major market players are focusing on developing more specific and sensitive monoclonal antibodies through advanced antibody engineering and humanization techniques. For instance, GenScript has developed CDR grafting technology that transfers the antigen-binding loops of a mouse antibody into a human antibody framework to generate humanized antibodies. Such technological advancements are expanding the applications of research antibodies in the development of highly selective therapeutics. Additionally, the increasing R&D spending by biopharmaceutical companies on proteomics and cellular analysis research is anticipated to boost the demand for research antibodies, thereby fueling the market growth over the forecast period.
Porter’s Analysis
Threat of new entrants: Low barriers of entry enable new players to enter the research antibodies market easily. However, established players have strong brand recognition and distribution networks.
Bargaining power of buyers: Researchers and research institutes have significant bargaining power as they can negotiate on price and demand customized antibodies as per their research needs.
Bargaining power of suppliers: Key players developing antibodies have strong bargaining power due to their specialized capabilities and intellectual property. Suppliers can increase prices of tailor-made antibodies.
Threat of new substitutes: No direct substitutes exist for research antibodies used in studies. However, alternative research methods can be used in some cases.
Competitive rivalry: Intense competition exists among key players due to their focus on developing innovative antibodies and expanding geographical presence.
Key Takeaways
The global Research Antibodies Market Growth is expected to witness high growth.
Regional analysis:
North America is expected to maintain its dominance in the research antibodies market during the forecast period. This can be attributed to rising government initiatives to support research activities and presence of key market players in the region. Asia Pacific is anticipated to showcase the fastest growth rate during 2023-2030 due to increasing pharmaceutical research expenditures by governments in China and India.
Key players:
Key players operating in the research antibodies market are Zoetis Inc., Elanco Animal Health, MSD Animal Health, Benchmark Holdings, Phibro Animal Health Corporation, Intervet Inc., Norvartis, Merck Animal Health, Novartis AG, Pharmaq AS, AquaBounty Technologies, Alltech, Skretting, Nutreco, Biomin. Zoetis Inc. and Elanco Animal Health account for major share due to their broad portfolio of monoclonal and polyclonal antibodies.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
